![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Beyer Jochen Hausmann Roland
Publisher: Govi-Verlag
ISSN: 2195-2175
Source: PHARMAKON, Vol.1, Iss.6, 2013-11, pp. : 456-462
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Nutt David
Journal of Substance Use, Vol. 8, Iss. 4, 2003-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Acute effects of drugs of abuse
Clinical Medicine, Vol. 3, Iss. 2, 2003-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Metabolism of Designer Drugs of Abuse
Current Drug Metabolism, Vol. 6, Iss. 3, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Synthetic Cannabinoids as Drugs of Abuse
Current Drug Abuse Reviews, Vol. 5, Iss. 2, 2012-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drugs of Abuse, Driving and Traffic Safety
Current Drug Abuse Reviews, Vol. 3, Iss. 1, 2010-01 ,pp. :